BioSpace News Archive

Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced that it has received a letter from The Nasdaq Stock Market LLC advising the Company that it has regaine

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its fourth quarter and year-end financial results on Tuesday, February 25, 2020 . Insmed management will host a conference call for in

Accomplished Biopharmaceutical and Drug Development Executive to Lead the Expansion of Enteris’ External and Internal Development Programs [10-February-2020] BOONTON, N.J. , Feb. 10, 2020 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiar

Large independent physician association serving California now offers access to Biocept’s Target Selector™ liquid biopsy testing for the management of patients diagnosed with cancer [10-February-2020] SAN DIEGO , Feb. 10, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clin

Certara®, the global model-informed drug development and decision support leader, today announced that its discovery research relationship with Arvinas has expanded to include a greater diversity of small molecule drug discovery projects and data sources.

Catalyst Health Network (Catalyst) and UnitedHealthcare’s accountable care organization (ACO) has led to a significant increase in preventive screenings as well as a reduction in health care costs in North Texas since launching in 2015.

Athersys, Inc. (Nasdaq: ATHX) will release its year-end 2019 financial results at approximately 4:00 PM Eastern Time on Monday, March 16, 2020, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Geisinger, one of the leading health systems serving Pennsylvania and New Jersey, has partnered with Omnicell to help drive clinical and operational efficiency, increase medication safety and reduce costs—ultimately supporting enhanced patient care.

CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended December 31, 2019.

Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces further positive data from its current investigational new drug (IND)-enabling studies for ALS-4,